Correction for Colussi et al., HDAC2 blockade by nitric oxide and histone deacetylase inhibitors reveals a common target in Duchenne muscular dystrophy treatment

Lignende værker

• HDAC2 blockade by nitric oxide and histone deacetylase inhibitors reveals a common target in Duchenne muscular dystrophy treatment
  af: Colussi, Claudia, et al.
  Udgivet: (2008)
• CRISPR Correction of Duchenne Muscular Dystrophy
  af: Min, Yi-Li, et al.
  Udgivet: (2018)
• Preclinical Studies in the mdx Mouse Model of Duchenne Muscular Dystrophy with the Histone Deacetylase Inhibitor Givinostat
  af: Consalvi, Silvia, et al.
  Udgivet: (2013)
• Nitric Oxide (NO) and Duchenne Muscular Dystrophy: NO Way to Go?
  af: Timpani, Cara A., et al.
  Udgivet: (2020)
• Correction: Sleiman et al., Hydroxamic Acid-Based Histone Deacetylase (HDAC) Inhibitors Can Mediate Neuroprotection Independent of HDAC Inhibition
  Udgivet: (2015)